These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33252832)

  • 21. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China.
    Yang SC; Hu S; Zhang SZ; Huang JW; Zhang J; Ji C; Cheng B
    J Immunol Res; 2018; 2018():4320195. PubMed ID: 29607330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
    Lam NS; Yang YH; Wang LC; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2004 Dec; 37(6):366-70. PubMed ID: 15599469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
    Chan L; Cook DK
    Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stevens-Johnson syndrome and toxic epidermal necrolysis in Hong Kong.
    Cheung CMT; Chang MM; Li JJX; Chan AWS
    Hong Kong Med J; 2024 Apr; 30(2):102-109. PubMed ID: 38531617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children.
    Koh MJ; Tay YK
    J Am Acad Dermatol; 2010 Jan; 62(1):54-60. PubMed ID: 19811851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens-Johnson syndrome and toxic epidermal necrolysis - retrospective review of cases in a high complexity hospital in Brazil.
    Medeiros MP; Carvalho CHC; Santi CG; Avancini J
    Int J Dermatol; 2020 Feb; 59(2):191-196. PubMed ID: 31173347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Tian XB; Liu W; Zhang LX
    J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients.
    Watanabe T; Go H; Saigusa Y; Takamura N; Watanabe Y; Yamane Y; Totsuka M; Ishikawa H; Nakamura K; Matsukura S; Kambara T; Takaki S; Yamaguchi Y; Aihara M
    Allergol Int; 2021 Apr; 70(2):229-234. PubMed ID: 33279401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
    Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
    Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies.
    Wu J; Lee YY; Su SC; Wu TS; Kao KC; Huang CC; Chang WC; Yang CH; Chung WH
    Br J Dermatol; 2015 Nov; 173(5):1224-31. PubMed ID: 26218033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Lomé (Togo). Evolutional and etiological profiles of 40 cases].
    Pitché P; Padonou CS; Kombate K; Mouzou T; Tchangai-Walla K
    Ann Dermatol Venereol; 2005; 132(6-7 Pt 1):531-4. PubMed ID: 16142100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.